Takip et
George Papatheodoridis
George Papatheodoridis
National and Kapodistrian University of Athens, Medical School
med.uoa.gr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
EASL clinical practice guidelines: management of chronic hepatitis B virus infection
G Papatheodoridis, M Buti, M Cornberg, HLA Janssen, D Mutimer, S Pol, ...
Journal of hepatology 57 (1), 167-185, 2012
5312*2012
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
P Lampertico, K Agarwal, T Berg, M Buti, HLA Janssen, ...
Journal of hepatology 67 (2), 370-398, 2017
52062017
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ...
Hepatology 78 (6), 1966-1986, 2023
30722023
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The Lancet Gastroenterology & Hepatology 2 (3), 161-176, 2017
22202017
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
16582018
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
PN Newsome, K Buchholtz, K Cusi, M Linder, T Okanoue, V Ratziu, ...
New England Journal of Medicine 384 (12), 1113-1124, 2021
14922021
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B
YF Liaw, E Gane, N Leung, S Zeuzem, Y Wang, CL Lai, EJ Heathcote, ...
Gastroenterology 136 (2), 486-495, 2009
9452009
Systematic review: the model for end‐stage liver disease–should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis?
E Cholongitas, GV Papatheodoridis, M Vangeli, N Terreni, D Patch, ...
Alimentary pharmacology & therapeutics 22 (11‐12), 1079-1089, 2005
6022005
Advancing the global public health agenda for NAFLD: a consensus statement.
JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ...
Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022
5962022
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
5762014
Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen–negative chronic hepatitis B
SJ Hadziyannis, GV Papatheodoridis, E Dimou, A Laras, C Papaioannou
Hepatology 32 (4), 847-851, 2000
5602000
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos (t) ide therapy: a systematic review
GV Papatheodoridis, P Lampertico, S Manolakopoulos, A Lok
Journal of hepatology 53 (2), 348-356, 2010
5592010
Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy
GV Papatheodoridis, HLY Chan, BE Hansen, HLA Janssen, P Lampertico
Journal of hepatology 62 (4), 956-967, 2015
5572015
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
G Papatheodoridis, G Dalekos, V Sypsa, C Yurdaydin, M Buti, J Goulis, ...
Journal of Hepatology 64 (4), 800-806, 2016
5302016
Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment
E Gane, E Lawitz, D Pugatch, G Papatheodoridis, N Bräu, A Brown, S Pol, ...
New England Journal of Medicine 377 (15), 1448-1455, 2017
513*2017
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ...
The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022
4812022
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a metaanalysis
GV Papatheodoridis, J Goulis, G Leandro, D Patch, AK Burroughs
Hepatology 30, 612-22, 1999
4481999
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡.
M Cornberg, AS Lok, NA Terrault, F Zoulim, T Berg, MR Brunetto, ...
Journal of Hepatology 72 (3), 539-557, 2020
427*2020
The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B
GV Papatheodoridis, E Manesis, SJ Hadziyannis
Journal of hepatology 34 (2), 306-313, 2001
4272001
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease
YF Liaw, IS Sheen, CM Lee, US Akarca, GV Papatheodoridis, ...
Hepatology 53 (1), 62-72, 2011
4222011
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20